Quantcast

Latest Rosiglitazone Stories

2011-10-13 21:15:00

Gilman Law LLP has over 30 years of experience in complex litigation and class actions involving serious defective drugs. If you or someone you know suffered any adverse side effects of Actos http://www.actos-bladdercancerlawsuits.com, such as bladder cancer or heart disease, or believe you were harmed in any way by taking Actos, you may have a claim for recovery. Bonita Springs, FL, (PRWEB) October 13, 2011 Gilman Law LLP, a leading national law firm, announces that it is now accepting...

2011-09-23 07:00:00

Ennis & Ennis, P.A. Explains that States with a Statute of Limitations of More Than One Year for Product Liability Cases May Still Have Time to File Claims Arising from the Use of Avandia (PRWEB) September 23, 2011 U.S. District Judge Cynthia M. Rufe, the presiding judge on the federal Avandia litigation cases, denied GlaxoSmithKlineâs Statute of Limitations Motion to Dismiss. GlaxoSmithKline (GSK), the manufacturer of Avandia, filed a Motion to Dismiss over 60 lawsuits,...

2011-09-09 14:38:40

Researchers from Dana-Farber Cancer Institute in Boston and the Scripps Research Institute in Jupiter, Fla., report they have created prototype drugs having powerful anti-diabetic effects, yet apparently free — at least in mice — of dangerous side effects plaguing some current diabetes medications. The researchers say that their “proof-of-principle” findings could lead to safer medications for Type 2 diabetes, which affects more than 25 million children and adults...

2011-09-05 11:23:24

Research offers hope for better treatments for diabetes patients In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch. The finding paves the way for the development of anti-diabetic therapeutics with minimal adverse side effects plaguing currently available drugs such as Avandia (rosiglitazone), scheduled to be removed from...

2011-04-12 07:00:00

ST. PAUL, Minn., April 12, 2011 /PRNewswire/ -- According to a new pharmacy benefit study, a point-of-sale automated electronic safety edit, designed to require provider prior authorization (PA) for members who have a rosiglitazone claim with concurrent use of insulin or nitrate (CIN), potentially decreased members' risk for myocardial ischemia. The study will be presented at the Academy of Managed Care Pharmacy's 23rd Annual Meeting in Minneapolis, Minn. by Prime Therapeutics (Prime), a...

2011-04-05 15:33:00

NEW YORK, April 5, 2011 /PRNewswire/ -- The latest news on the much publicized Avandia Settlement's is: there is no news. After a Bloomberg report made public last summer that many of the Avandia suits were coming to a settlement range of approximately $86,000.00 per suit, no new news has come into the market. This has left many suffering Avandia plaintiffs with more confusion -and concern- when they will actually get their settlement money. This has led to many Avandia Plaintiffs to...

2011-03-18 14:54:42

Research: Comparative cardiovascular effects of thiazolidinediones: Systematic review and meta-analysis of observational studies A new study published on bmj.com today adds to mounting evidence that rosiglitazone - a drug used to treat type 2 diabetes - is associated with an increased risk of major heart problems. It finds that rosiglitazone is associated with significantly higher odds of congestive heart failure, heart attack and death compared with a similar drug (pioglitazone)....

2011-03-15 15:42:30

The prevalence of type 2 diabetes is dramatically increasing throughout the world. Insulin resistance is a hallmark of type 2 diabetes, and it most often precedes the onset of hyperglycemia and predicts development of type 2 diabetes. At present, thiazolidinediones (TZD), the agonists of the peroxisome proliferators-activated receptor ÃŽ³, are the main agents to improve insulin sensitivity in the liver, adipose tissue, and skeletal muscle, thus improving glycaemic control in...

2011-03-15 13:21:36

Johns Hopkins researchers examine newest medications, find they come up short An inexpensive type 2 diabetes drug that has been around for more than 15 years works just as well and has fewer side effects than a half-dozen other, mostly newer and more expensive classes of medication used to control the chronic disease, new Johns Hopkins research suggests. In their report, published online March 14 in the journal Annals of Internal Medicine, the Hopkins team found that metformin, an oral drug...

2011-02-16 11:42:00

FAIRFIELD, N.J., Feb. 16, 2011 /PRNewswire/ -- The Lawsuit Settlement Funding Co., Legal-Bay LLC, announced that applications for Avandia pharmaceutical "lawsuit funding" were up over 500% in the month of January alone. The Lawsuit Settlement Funding Co. attributed the increased activity to their newly launched web-site: lawsuitssettlementfunding.com, which was announced on Jan. 12, 2011. Legal-Bay LLC, was already an industry leader in the pre-settlement funding for Avandia...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related